
Doxjafy M 400mg/10mg Tablet SR
Marketer
Kiama Lifesciences
Salt Composition
Doxofylline (400mg) + Montelukast (10mg)
Overview Doxjafy M 400mg/10mg Tablet SR
RespirAid-M 400mg/10mg Extended-Release Tablets combine medications to manage and prevent asthma attacks. This treatment relaxes airway muscles, improving airflow and easing breathing difficulties. It also alleviates allergic symptoms such as nasal discharge, sneezing, throat discomfort, eye watering, and nasal congestion. RespirAid-M is administered with or without food, following your doctor's prescribed dosage and schedule. Your individual dose will be determined by your condition and response to treatment. Continue taking this medication as directed; premature discontinuation may lead to symptom recurrence and condition worsening. Inform your physician of all other medications you are using, as interactions are possible. Common side effects include nausea, vomiting, abdominal pain, headache, sleep disturbances, mood changes, increased pulse rate, and flu-like symptoms. Most side effects are transient and self-limiting. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol should be avoided due to potential for increased drowsiness. Prior to commencing treatment, inform your doctor of any kidney or liver conditions to ensure appropriate dosage. Disclose any pregnancy, pregnancy plans, or breastfeeding.
Uses of Doxjafy M 400mg/10mg Tablet SR
Managing and mitigating asthma
Major Benefits of Doxjafy M 400mg/10mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Doxjafy M 400mg/10mg Tablet SR whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistency in timing is recommended. To maximize efficacy, avoid consuming Doxjafy M 400mg/10mg Tablet SR alongside caffeine or chocolate, including foods and beverages containing them, like tea and cocoa.
Common Side effects of Doxjafy M 400mg/10mg Tablet SR:
- Nausea
- Vomiting
- Headache
- Abdominal pain
- Diarrhea
- Upper respiratory tract infection
- Rash
- Fever
- Epigastric pain
- Tachycardia
- Extrasystoles
- Increased respiratory rate
- Pharyngitis
- Cough
- Increased liver enzymes
- Otitis media (infection of ear)
- Influenza
- Runny nose
- Sinus inflammation
How to use Doxjafy M 400mg/10mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Doxjafy M 400mg/10mg SR Tablets. Swallow the tablets whole; do not crush, chew, or break them. These tablets can be taken with or without food, but consistent timing is recommended. To maximize effectiveness, avoid consuming Doxjafy M 400mg/10mg SR Tablets with caffeine or chocolate, including foods and beverages containing them like tea and cocoa products.
How Doxjafy M 400mg/10mg Tablet SR works:
Each Doxjafy M SR tablet (400mg/10mg) contains a dual-drug formulation.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Doxjafy M 400mg/10mg Tablet SR concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Data on Doxjafy M 400mg/10mg Tablet SR use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingSAFE IF PRESCRIBED
Extended-release Doxjafy M 400mg/10mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Doxjafy M 400mg/10mg Extended-Release tablets could reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the application of Doxjafy M 400mg/10mg SR tablets in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Doxjafy M 400mg/10mg Tablet SR cautiously, potentially requiring dose modification. Consult a physician for guidance. Data regarding the use of Doxjafy M 400mg/10mg Tablet SR in such patients is limited. Dosage alterations are not advised for individuals with mild to moderate liver dysfunction.
What if you forget to take Doxjafy M 400mg/10mg Tablet SR :
Should you forget to take your Doxjafy M 400mg/10mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Doxjafy M 400mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
